Full Press Release Details
Appoints Seed & Trait Veteran Bryan Corkal to New Chief Financial
of Senior Leadership Team Further Solidifies Calyxt's Mission to Bring
Foods with Healthier Characteristics to Market Faster & More Efficiently
ST. PAUL, Minn.--(BUSINESS WIRE)--December 5, 2016--Calyxt, Inc., a
Minnesota-based company developing healthier food products to benefit
both consumers and growers, announced today the appointment of former
Monsanto executive Bryan Corkal to the new role of Chief Financial
Officer at Calyxt. Mr. Corkal will work closely with Calyxt's executive
team to further the Company's mission to develop crops and food products
with healthier characteristics and manage the Company's finance function
"Bryan brings a significant depth and breadth of experience in the
agricultural seeds and traits space. After nearly two decades at
Monsanto - Bryan has led efforts in finance, investor relations,
strategy, manufacturing finance and M&A over the years - Bryan's
extensive professional background in this space makes him the right
choice to build up Calyxt's management team as the company prepares to
launch its first products commercially," said Federico Tripodi, Calyxt
CEO. "Bryan has an impressive track record - from implementing a supply
chain transformation in his most recent role at Monsanto to designing a
new financial planning and consolidation system for North America. As a
result, I am confident that Bryan will hit the ground running at Calyxt
and prove to be a valuable member of our growing senior management team."
Mr. Corkal joins Calyxt from Monsanto, where he spent over 17 years in a
variety of key financial roles. Most recently, he served as North
America and Latin America North Supply Chain Finance Lead, where he was
responsible for the financial leaderships of the manufacturing and
logistics functions for Monsanto's seed and trait business with a total
annual product cost of over $2B. Mr. Corkal prior roles included serving
as Director of Investor Relations, before which he was the CFO for the
Latin America North region for Monsanto in Mexico City.
Additionally, over the years, Mr. Corkal has taken part in several key
acquisitions, analyzed new product platforms and even implemented a
Center of Excellence in Mexico City for Latin America North, where he
improved levels of service and controls while providing meaningful
development opportunities to a large international organization.
"The agricultural food supply chain is a complex system that presents
multiple opportunities to profitably deliver products to consumers and
growers," said Mr. Corkal. "I believe gene editing represents the next
big wave of innovation that will mark the future of food and agriculture
and am excited to join Calyxt as a pioneer in this space. We are now in
a unique position to use innovation and precise technology to improve
the quality of our foods while meeting challenges that are related to
sustainable growth and climate change. I am eager to bring my leadership
and expertise so that Calyxt can responsibly and profitably contribute
to addressing societal needs through health and nutrition."
Calyxt, Inc. is a fast-growing, consumer-oriented ag company that
utilizes its innovative, patented TALEN
technology to usher in a new era of agriculture and develop crop
products with healthier characteristics for consumers - all the while
helping farmers and food and agriculture industries reduce their
environmental footprints in the context of climate change. Calyxt
believes that agricultural technologies can have a profound, positive
impact on humanity and is looking to engage those who share this passion
for food and agriculture. Calyxt is located in Minneapolis-St. Paul,
Minn., and is a wholly owned subsidiary of Cellectis.
For further information please visit our website: www.calyxt.com
Calyxt and the corporate logo are trademarks owned by Calyxt, Inc.
Talking about gene editing? We do it.
TALEN is a registered trademark owned by the Cellectis
For further information:
Strategic Communications
Caitlin Kasunich, 212-896-1241
Simon Harnest, 646-385-9008
VP Corporate Strategy